In Vitro and In Vivo Activities of Gatifloxacin against Mycobacterium tuberculosis

Gatifloxacin (GAT) and moxifloxacin (MXF) were evaluated in vitro to determine their activities against Mycobacterium tuberculosis. GAT was subsequently compared in a dose range study to isoniazid (INH) in a murine tuberculosis model. GAT was somewhat less active than INH. GAT and MXF were evaluated...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Alvirez-Freites, Enrique J., Carter, Janna L., Cynamon, Michael H.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127120/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11897584/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.4.1022-1025.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!